Hims Weight Loss Review 2026: Best App, But Is It Worth $199/mo?
Hims & Hers is the largest consumer telehealth brand in the United States — built on hair loss and ED prescriptions before expanding into GLP-1 weight loss. In this Hims weight loss review, we score their compounded semaglutide and tirzepatide program using the same 25/25/20/15/15 methodology applied to every provider in our ranking. Bottom line upfront: Hims earns the highest app-experience score we've given any clinic, but at $199/mo the value equation is harder to justify when verified alternatives start at $133–$149/mo with equal or better clinical scores.
| Our Score | 8.1 / 10 (#4 in our ranking) |
| Starting Price | ~$199/mo (compounded semaglutide) |
| Compounded Tirz | Available |
| Oral / Sublingual | Available |
| Brand-Name GLP-1 | Not available |
| US Coverage | Nationwide (all 50 states) |
| Price Verified | 2026-07-21 (public health journalism) |
| Partnership | Editorial only — no affiliate deal with Hims |
Short answer: Hims & Hers runs a legitimate, well-resourced GLP-1 program through their FDA-registered compounding pharmacy with licensed US prescribers. The app experience is genuinely best-in-class. The catch: $199/mo is a brand premium — you're paying for Hims' name and polish, not superior clinical outcomes. Several of our Katalys-vetted partners deliver equivalent or better clinical oversight at meaningfully lower prices.
Independent Editor · Scores based on our editorial policy · Verified 2026-07-21 · Independently researched
What Is the Hims Weight Loss Program?
Before we get into the full Hims weight loss review details, some context. Hims & Hers (NYSE: HIMS) was founded in 2017 as a men's telehealth platform for hair loss and erectile dysfunction, then expanded into women's health, mental health, and primary care before launching their GLP-1 weight-loss program in 2023–2024. Today they operate one of the largest direct-to-patient compounded GLP-1 programs in the country, with a dedicated mobile app, an FDA-registered compounding pharmacy, and a network of US-licensed prescribers reviewing each case.
The program works like most GLP-1 telehealth pathways:
- Complete a digital health intake (typically 10–15 minutes via the Hims app or web)
- A licensed US physician reviews your health history and determines eligibility
- If approved, a prescription is sent to their FDA-registered compounding pharmacy
- Medication ships directly to your door — typically within a few business days
- Ongoing titration guidance and provider check-ins through the app
What distinguishes Hims structurally is that they operate their own compounding pharmacy rather than outsourcing to a third-party compounder. This matters for quality control and chain-of-custody accountability in ways that smaller white-label programs cannot match.
Hims Weight Loss Review: Pricing in 2026
Compounded semaglutide starts at approximately $199/month through Hims & Hers, based on pricing reported across CNBC, Forbes Health, and Healthline coverage from 2025–2026. Compounded tirzepatide and oral/sublingual semaglutide carry separate price points.
Before signing up, three cost realities are worth understanding:
Starting dose ≠ maintenance dose. GLP-1 programs begin at the lowest titration dose (typically 0.25mg/week semaglutide). As your dose increases toward maintenance levels — which is where most patients spend most of their time — monthly costs rise. This is industry-wide, not Hims-specific, but it deserves clear disclosure.
No brand-name Wegovy or Zepbound. Hims & Hers offers compounded semaglutide and tirzepatide only. If your insurance covers brand-name Wegovy or Zepbound, or you prefer the FDA-approved formulation, Hims cannot fill that prescription. The only provider in our current ranking that pairs brand-name GLP-1 access (Wegovy/Ozempic/Zepbound) with compounded options is Wellorithm.
$199/mo is a significant premium. Our full ranking includes providers at comparable or higher clinical quality for $50–$66 less per month:
| Provider | Starting Price | Brand-Name | Score | Our Role |
|---|---|---|---|---|
| Hims & Hers | ~$199/mo | No | 8.1/10 | Editorial only |
| Wellorithm | $147/mo | Yes (Wegovy/Ozempic) | 8.3/10 | Partner |
| Gala Health | $149/mo | No | 8.3/10 | Partner |
| Yucca Health | from $146/mo | No | 7.8/10 | Partner |
| Oak | $133/mo | No | 7.7/10 | Partner |
⚠️ Disclosure: We have active affiliate partnerships with Wellorithm, Gala Health, Yucca Health, and Oak and may earn a commission if you sign up through our links. We receive no commission from Hims & Hers; this is an independent editorial review. Our scores are derived from our editorial policy — commission has never influenced a score on this site.
If price is a deciding factor, our Hims weight loss review finds the cheapest compounded GLP-1 programs we have vetted start at $99–$133/mo with full clinical oversight.
Clinical Quality: Pharmacy Standards and Physician Oversight
Our clinical quality criterion carries 25% of the total score — the highest single weight in our methodology. Hims earns 8.0/10 here, driven by their pharmacy infrastructure.
What earns that score:
- FDA-registered compounding pharmacy. Hims compounds in-house under a 503A model, meaning a licensed US pharmacist prepares each prescription for an identified patient. This is the same legal framework the DEA and state boards of pharmacy regulate most closely — it is not the looser 503B bulk-compounding model.
- Licensed US prescribers. Every Hims prescription is reviewed by a licensed physician or nurse practitioner before dispensing. No auto-approval.
- Compounding not FDA-approved — this is standard but matters. Compounded semaglutide and tirzepatide are legally available under 503A but are not FDA-approved finished drugs. The FDA has clarified that compounding pharmacies may still compound these medications for individual patients under certain conditions. For the current legal status, see our guide: Is Compounded Semaglutide Still Legal in 2026?
- HIPAA-compliant data handling. As a NYSE-listed public company, Hims operates under more rigorous regulatory scrutiny than most telehealth startups — patient data practices are independently audited.
What holds the score below 8.5 in this Hims weight loss review: The clinical score reflects that Hims' prescribers are generalists, not obesity-medicine specialists. For comparison, providers like Mochi Health specifically credential obesity-specialist physicians, which earns them a higher clinical sub-score despite similar infrastructure.
Treatment Options: Compounded Sema, Tirz, and Oral Formats
Hims earns 8.5/10 on treatment range — one of the stronger menus in the category. Their formulary includes:
- Compounded semaglutide (injection) — the core offering; weekly self-injection, standard titration protocol
- Compounded tirzepatide (injection) — dual GIP/GLP-1 agonist; higher price point, stronger average weight-loss data in clinical trials
- Oral / sublingual semaglutide — dissolved under the tongue; lower bioavailability than injection but suitable for needle-averse patients
The availability of both injectable and oral/sublingual formulations at no format surcharge is a genuine differentiator — one of the positives in any Hims weight loss review. Many budget-focused providers offer injection-only plans. For the full science on oral semaglutide efficacy and bioavailability trade-offs, see: Oral Semaglutide Safety: What Research Shows.
What's not on the menu: No brand-name GLP-1. If your weight-loss trajectory stalls on compounded and you want to transition to Wegovy or Zepbound, you'd need to switch providers.
The Hims App Experience: Best in Category
In every Hims weight loss review category, the experience score stands apart from the rest of the ranking. We score experience at 9.0/10 — the highest experience score in our entire ranking. This reflects:
- Frictionless onboarding. The Hims intake flow is widely cited in patient reviews as the fastest and least frustrating in consumer telehealth. From account creation to prescription submission typically takes under 15 minutes.
- Polished mobile app. Hims' app handles messaging with your provider, refill requests, titration reminders, and shipment tracking in one place. Consumer review platforms consistently rate the Hims digital experience at 4+ stars, which is unusual in a category where complaint rates are high.
- Discreet packaging. All orders ship in plain, unmarked packaging — a detail that matters to a meaningful share of GLP-1 patients.
- Nationwide delivery. Hims ships to all 50 US states.
- Fast provider response times. Patient reviews note provider response times of 24–48 hours for titration questions, which is above average.
The app experience gap between Hims and most of our vetted Katalys partners is real — if you've tried a clunky intake portal at another telehealth company, the Hims flow is a noticeable improvement. Whether that UX premium is worth $50–$66/mo more per month is the core question this Hims weight loss review is designed to help you answer.
Transparency and Trust: Public Company Disclosures
Hims earns 8.5/10 on transparency — reflecting the structural advantages of being a NYSE-listed, publicly traded company.
- Pricing is publicly displayed before you complete intake. Not all GLP-1 telehealth providers show pricing upfront — many require you to answer 15 health questions before revealing cost.
- Compounding disclosures are present. Hims clearly states that their semaglutide and tirzepatide are compounded and not FDA-approved finished drugs.
- Pharmacy credentials are disclosed. Their compounding pharmacy's FDA registration status and 503A operational framework are documented in their clinical FAQ.
- No LegitScript flag. Hims operates within the scope of US telehealth law without the safety red flags (offshore pharmacy, prescription-free dispensing, unverified claims) that LegitScript monitors for.
- SEC filings provide additional accountability. As a public company, Hims' material risks — including regulatory risks around compounding — are disclosed in quarterly and annual SEC filings, creating a level of transparency that private telehealth startups are not required to provide.
Who the Hims Weight Loss Program Is Right For
Choose Hims if:
- You already use Hims for another condition (hair loss, ED) and want a single platform for all your telehealth
- You specifically want the best mobile app experience in the GLP-1 category
- You value the accountability of a major NYSE-listed company over a smaller telehealth startup
- You need both injectable and oral/sublingual formats available under one plan
Consider an alternative if:
- Price matters: at $199/mo, you're paying $50–$66/mo more than clinically equivalent providers like Gala Health ($149/mo, 8.3/10) or Wellorithm ($147/mo, 8.3/10 — and the only provider offering actual brand-name Wegovy)
- You want brand-name GLP-1 (Wegovy/Zepbound): Hims only offers compounded versions
- You need aggressive cost management: Oak starts at $133/mo with no subscription lock-in, scoring 7.7/10
Hims vs Wellorithm: Which Is Better?
The most direct comparison for the Hims weight loss program is Wellorithm, our #2-ranked provider (8.3/10). Both are full-service GLP-1 telehealth programs. The differences are meaningful:
| Hims & Hers | Wellorithm | |
|---|---|---|
| Score | 8.1/10 | 8.3/10 |
| Starting price | ~$199/mo | $147/mo |
| Brand-name GLP-1 | No | Yes (Wegovy, Ozempic, Zepbound) |
| Compounded sema | Yes | Yes |
| Compounded tirz | Yes | Yes |
| Oral/sublingual | Yes | Yes |
| App experience | Best-in-class | Good |
| Our relationship | Editorial | Affiliate partner |
Wellorithm is the only provider in our ranking that gives patients access to all three tracks: compounded, brand-name injectable, and oral/needle-free — at $52/mo less than Hims' starting price. For most patients, the math resolves clearly in Wellorithm's favor. The one scenario where Hims wins: you're already a Hims subscriber and convenience of a single account outweighs the cost difference.
This Hims weight loss review covers semaglutide and tirzepatide options — you can compare the full provider breakdown on our /compare/wellorithm-vs-hims page.
Frequently Asked Questions
Is the Hims weight loss program legitimate?
Yes. Hims & Hers is a NYSE-listed public company operating an FDA-registered compounding pharmacy with licensed US prescribers reviewing every prescription. Their compounded semaglutide and tirzepatide are legal under the 503A framework. The program meets all our clinical and legal-compliance checkpoints. Our Hims weight loss review found no red flags on LegitScript criteria, licensing, or patient-safety practices.
Is compounded semaglutide from Hims FDA-approved?
No — and this is true of all compounded GLP-1 medications, not just Hims. The FDA has approved brand-name Wegovy (semaglutide) and Zepbound (tirzepatide), but not compounded versions. Hims' compounded semaglutide is legal to dispense under 503A for identified patients with a valid prescription. The FDA's guidance on compounded GLP-1 medications clarifies that state-licensed pharmacies may compound semaglutide and tirzepatide for individual patients under a valid prescription. For the full regulatory picture, see our guide on whether compounded semaglutide is still legal in 2026.
How much does Hims weight loss cost per month?
Compounded semaglutide starts at approximately $199/mo. As your titration dose increases, monthly costs rise — this is standard across all GLP-1 telehealth providers. For context, verified alternatives in our ranking start at $133/mo (Oak), $146–$206/mo (Yucca Health), and $147/mo (Wellorithm, which also includes brand-name Wegovy access). See our full GLP-1 cost breakdown.
Does Hims take insurance for weight loss?
Hims operates on a direct-pay model — they do not bill insurance for compounded GLP-1 medications. If you have employer insurance that covers brand-name Wegovy or Zepbound, you'd need a provider that can navigate insurance formularies, which Hims does not currently offer for weight loss. Wellorithm is currently the only provider in our ranking that handles both compounded and brand-name GLP-1 prescriptions.
What states does Hims ship GLP-1 to?
Hims ships compounded semaglutide and tirzepatide to all 50 US states, subject to state telehealth prescribing regulations at the time of your prescription.
Hims Weight Loss Review Verdict: 8.1/10
This Hims weight loss review resolves to a straightforward conclusion: this is a real, well-run program from the most recognizable name in consumer telehealth. Their app experience is genuinely the best in the GLP-1 category (9.0/10), their pharmacy infrastructure is solid, and their transparency as a public company adds accountability that smaller startups cannot match.
The honest trade-off: you pay a brand premium. At $199/mo, Hims costs $50–$66 more per month than our top-scoring Katalys-vetted partners, who deliver equal or better clinical outcomes. Over 12 months, that's $600–$792 extra for an app that's nicer to look at. That math favors Hims only if the UX premium has real value to you personally — or if you're already embedded in the Hims ecosystem for other conditions.
For most first-time GLP-1 patients comparing options, we recommend starting with Wellorithm (8.3/10, $147/mo, brand-name GLP-1 available) or Gala Health (8.3/10, $149/mo, Best Overall) before committing to the Hims price point.
Top Picks (Our Vetted Partners)
Why we list alternatives: We earn no commission from Hims & Hers. These are providers we have independently scored and hold active Katalys partnerships with — commission never influences our scoring methodology.
| Provider | Score | Starting Price | Best For |
|---|---|---|---|
| Wellorithm | 8.3/10 | $147/mo | Brand-name Wegovy + compounded |
| Gala Health | 8.3/10 | $149/mo | Best Overall |
| Yucca Health | 7.8/10 | from $146/mo | Best LegitScript value |
| Oak | 7.7/10 | $133/mo | Cheapest, no lock-in |
Related Reading
- GLP-1 Weight Loss Cost in 2026: What You'll Actually Pay
- Compounded vs Brand Semaglutide: Cost, Safety & How to Choose
- Oral Semaglutide Safety: What Research Shows
- Is Compounded Semaglutide Still Legal in 2026?
- Best Online Semaglutide Providers 2026 (Ranked & Verified)
Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. Compounded semaglutide and tirzepatide are not FDA-approved finished drugs. Consult a licensed healthcare provider before starting any GLP-1 weight-loss program.
Affiliate disclosure: MyGLP1 Guides earns commissions from Wellorithm, Gala Health, Yucca Health, and Oak when readers sign up through our links. Hims & Hers is reviewed independently with no commercial relationship. See our affiliate disclosure for full details.
Last updated: July 2026



